Presentation on the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026 is attached
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Agarwal's Health Care, India's largest eye care services chain, reported strong FY26 results with total income of ₹2,125 Cr, up 20.9% YoY. EBITDA grew 22.2% to ₹614 Cr with margins expanding to 28.9%, while PAT surged 52.4% to ₹168 Cr. The company added 57 facilities during the year (one per week), expanding to 288 total facilities across 269 in India and 19 in Africa. Same-store sales growth stood at 14.1%, with emerging facilities contributing 21.3% of revenues. The company achieved a net cash position of ₹124 Cr, improving from net debt of ₹267 Cr in FY25. Key operational metrics include 3 million+ patients served, 323,000+ surgeries performed, and 968 doctors.
Strong operational and financial performance with margin expansion and cash generation indicates healthy business execution. The rapid facility expansion and solid same-store growth suggest continued market share gains in the fragmented eye care market.